Nicolas Martelli1, Paul Hansen2, Hélène van den Brink3, Aurélie Boudard4, Anne-Laure Cordonnier4, Capucine Devaux5, Judith Pineau5, Patrice Prognon5, Isabelle Borget6. 1. Pharmacy Department, Georges Pompidou European Hospital, AP-HP, 20 rue Leblanc, 75015 Paris, France; University Paris-Sud, GRADES, Faculty of Pharmacy, 5 rue Jean-Baptiste Clément, 92290 Châtenay-Malabry, France. Electronic address: nicolas.martelli@aphp.fr. 2. Department of Economics, University of Otago, Dunedin 9054, New Zealand. 3. University Paris-Sud, GRADES, Faculty of Pharmacy, 5 rue Jean-Baptiste Clément, 92290 Châtenay-Malabry, France. 4. Therapeutic Evaluation Unit, General Agency of Equipment and Health Products, AP-HP, 7, rue du Fer à Moulin, 75005 Paris, France. 5. Pharmacy Department, Georges Pompidou European Hospital, AP-HP, 20 rue Leblanc, 75015 Paris, France. 6. University Paris-Sud, GRADES, Faculty of Pharmacy, 5 rue Jean-Baptiste Clément, 92290 Châtenay-Malabry, France; Department of Health Economics, Gustave Roussy Institute, 114, rue Edouard-Vaillant, 94805 Villejuif, France.
Abstract
BACKGROUND: At the hospital level, decisions about purchasing new and oftentimes expensive medical devices must take into account multiple criteria simultaneously. Multi-criteria decision analysis (MCDA) is increasingly used for health technology assessment (HTA). One of the most successful hospital-based HTA approaches is mini-HTA, of which a notable example is the Matrix4value model. OBJECTIVES: To develop a funding decision-support tool combining MCDA and mini-HTA, based on Matrix4value, suitable for medical devices for individual patient use in French university hospitals - known as the IDA tool, short for 'innovative device assessment'. METHODS: Criteria for assessing medical devices were identified from a literature review and a survey of 18 French university hospitals. Weights for the criteria, representing their relative importance, were derived from a survey of 25 members of a medical devices committee using an elicitation technique involving pairwise comparisons. As a test of its usefulness, the IDA tool was applied to two new drug-eluting beads (DEBs) for transcatheter arterial chemoembolization. RESULTS: The IDA tool comprises five criteria and weights for each of two over-arching categories: risk and value. The tool revealed that the two new DEBs conferred no additional value relative to DEBs currently available. CONCLUSIONS: Feedback from participating decision-makers about the IDA tool was very positive. The tool could help to promote a more structured and transparent approach to HTA decision-making in French university hospitals.
BACKGROUND: At the hospital level, decisions about purchasing new and oftentimes expensive medical devices must take into account multiple criteria simultaneously. Multi-criteria decision analysis (MCDA) is increasingly used for health technology assessment (HTA). One of the most successful hospital-based HTA approaches is mini-HTA, of which a notable example is the Matrix4value model. OBJECTIVES: To develop a funding decision-support tool combining MCDA and mini-HTA, based on Matrix4value, suitable for medical devices for individual patient use in French university hospitals - known as the IDA tool, short for 'innovative device assessment'. METHODS: Criteria for assessing medical devices were identified from a literature review and a survey of 18 French university hospitals. Weights for the criteria, representing their relative importance, were derived from a survey of 25 members of a medical devices committee using an elicitation technique involving pairwise comparisons. As a test of its usefulness, the IDA tool was applied to two new drug-eluting beads (DEBs) for transcatheter arterial chemoembolization. RESULTS: The IDA tool comprises five criteria and weights for each of two over-arching categories: risk and value. The tool revealed that the two new DEBs conferred no additional value relative to DEBs currently available. CONCLUSIONS: Feedback from participating decision-makers about the IDA tool was very positive. The tool could help to promote a more structured and transparent approach to HTA decision-making in French university hospitals.